encoding seasonal influenza haemagglutinin (HA) glycoproteins: A/H1N1 EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07B
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005639
Compound index — E
660 substances begin with E. 8 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, encoding seasonal… – Esafoxolaner.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
encoding the N-terminal domain and receptor-binding domain of the viral spike (S) protein of SARS-CoV-2 EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BN01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005640
encoding the viral spike (S) protein of SARS-CoV-2 EU-MED Not yet graded
EU medicine: Authorised, Withdrawn from rolling review
Class as recordedJ07BN01; J07BX03
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005641
endo-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005643
Endoglin US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005644
Endothjelial (syn.: L-5-methyltetra-hydrofolic acid, calcium salt; Vitamin B9), MetafolinTM EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps keep arteries/blood vessels healthy; Contributes to healthy arteries/ blood vessels; Supports heart health by contributing to the normal functioning of the arteries/blood vessels; Helps maintain a normal blood pressure by supporting the elasticity of blood vessels/arteries.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005645
Enfamil® Premium, containing docosahexaenoic acid (DHA) and arachidonic acid (ARA) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Enfamil® Premium contributes to optimal brain development of infants and young children” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005646
enflicoxib EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005647
Enflurane US-DRUG Not yet graded
Earliest US approval1972
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005648
Enfortumab Vedotin-Ejfv US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2019
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005650
Engelhardtia chrysolepis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005652
English Sole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Dietary [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005653
English Walnut US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence27 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005654
Enlicitide Decanoate US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2026
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005655
Enobosarm ETALYNUS-DRUG C/supportedband 2
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005657
Enoxacin US-DRUG Not yet graded
Earliest US approval1991
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005658
Enoxaparin Sodium EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, LapsedUS: anda
Class as recordedB01AB05; Heparin; Low Molecular Weight Heparin [EPC]; Low-Molecular-Weight [CS]
Earliest US approval1993
Market presence172 US product listings · 13 FDA applications · 2 EU medicines
Etalyn identifierETA-C-005659
Enoxolone US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005660
Enrofloxacin US-DRUG Not yet graded
US: bulk ingredient
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005661
Ensartinib Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2024
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005662
Ensifentrine EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: bulk ingredient
Class as recordedPhosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]; Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
Earliest US approval2024
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005663
Ensitrelvir US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2026
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005664
ensitrelvir fumaric acid EU-MED Not yet graded
EU medicine: Opinion
Class as recordedJ05AE16
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005665
Ensulizole US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAdenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence103 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005666
Entacapone EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAmino Acids; Aromatic Amino Acid [EPC]; Aromatic [CS]; Catechol O-Methyltransferase Inhibitors [MoA]
Earliest US approval1999
Market presence56 US product listings · 17 FDA applications · 7 EU medicines
Etalyn identifierETA-C-005667
Entada phaseoloides CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005668
Entamoeba Histolytica US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005669
Entecavir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; J05AF10; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
Earliest US approval2005
Market presence47 US product listings · 20 FDA applications · 2 EU medicines
Etalyn identifierETA-C-005670
Enterobacter Cloacae US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005671
Enterobius Vermicularis US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Allergens [CS]; Blood Coagulation Factor [EPC]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005672
Enterococcinum CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005673
Enterococcus durans EU-NOVEL Not yet graded
Not novel in food
also: Streptococcus durans
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005674
Enterococcus Faecalis CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in supplementsCA licensed ingredientUS: drug for further processing
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence43 US product listings · 2 Canadian licensed products
Parts in scopeWhole
Etalyn identifierETA-C-005675
Enterococcus faecium R0026 CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005676
Enterococcus faecium T-110 CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005677
Enterococcus lactis CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in foodCA licensed ingredientUS: unapproved homeopathic
also: Enterococcus Faecium; Streptococcus faecium (some strains)
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence5 US product listings · 4 Canadian licensed products
Parts in scopeWhole
Etalyn identifierETA-C-005678
Enterovirus 71 US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005679
Entolimod EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedL03A
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005680
Enzalutamide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedAndrogen Receptor Antagonists [MoA]; Androgen Receptor Inhibitor [EPC]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]
Earliest US approval2012
Market presence26 US product listings · 9 FDA applications · 3 EU medicines
Etalyn identifierETA-C-005682
Enzymatically modified isoquercitrin CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005683
enzyme blend CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005684
Eosinum natrum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005685
EPA and DHA fatty acids EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to regulate the blood sugar leve” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005686
EPA and DHA Omega-3 fatty acids EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Omega-3 EPA and DHA help maintain healthy joints” | Non-authorised | Art.13(1) | EFSA opinion |
| “Omega-3 EPA and DHA support normal emotional wellbeing” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005687
Epcoritamab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedBispecific CD20-directed CD3 T Cell Engager [EPC]; CD20-directed Antibody Interactions [MoA]; CD3 Receptor Agonists [MoA]; CD3-directed Antibody Interactions [MoA]
Market presence3 US product listings · 1 EU medicines
Etalyn identifierETA-C-005688
Epcoritamab-Bysp US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005689
Ephedra Distachya Flowering Twig US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence17 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005690
Ephedra equisetina CA-NHP Not yet graded
CA licensed ingredient
Market presence115 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005691
Ephedra intermedia CA-NHP Not yet graded
CA licensed ingredient
Market presence170 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005692
Ephedra Nevadensis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005693
Ephedra sinica CA-NHP Not yet graded
CA licensed ingredient
Market presence158 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005694
Ephedra vulgaris CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005695
Ephedrine CA-NHPETALYNUS-DRUG B/supportedband 1
CA licensed ingredientUS: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Increased Norepinephrine Activity [PE]; Norepinephrine Releasing Agent [EPC]
Earliest US approval2016
Market presence56 US product listings · 24 FDA applications · 24 Canadian licensed products
Etalyn identifierETA-C-005696
Epiandrosterone ETALYN E/insufficientband 6
also: 3beta-androsterone; 3β-hydroxy-5α-androstan-17-one
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-005697
Epichlorohydrin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005698
Epicoccum Nigrum US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antigens
Market presence20 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005699
Epidermophyton Floccosum US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005700
Epifagus Virginiana Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005701
Epigallocatechin gallate (ECGC) + caffeine EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Increases burning of calories. Stimulates your metabolism to burn calories. Stimulates your body to enhance the calorie burning process. Stimulates your metabolism. Three servings per day have been shown to increase calorie burning by approximately 106 calories. Symbol included in the claim: Brand included in the claim: ENVIGA™ CALORIE BURNER – INVIGORATE YOUR METABOLISM” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005704
Epilobii herba EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Willow herb; Epilobium angustifoliumL.;Epilobium parviflorumSchreb.
Class as recordedherbal: Urinary tract and genital disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-005705
Epilobium angustifolium CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005706
Epilobium angustifolium L. EU-NOVEL Not yet graded
Not novel in food
also: Fireweed; Great Willow-herb; Rosebay Willowherb
Parts in scopeLeaves including young sprouts, shoots and stems and infusion of the herb; Aerial parts
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005707
Epilobium palustre CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005708
Epilobium parviflorum CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005709
Epimedium CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005710
Epimedium brevicornu CA-NHP Not yet graded
CA licensed ingredient
Market presence415 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005711
Epimedium Brevicornu TOP US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005712
Epimedium brevicornum CA-NHP Not yet graded
CA licensed ingredient
Market presence77 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005713
Epimedium Grandiflorum TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005716
Epimedium koreanum CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005717
Epimedium macranthum EU-NOVEL Not yet graded
Epimedium Pubescens Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005719
Epimedium sagittatum CA-NHPEU-NOVEL Not yet graded
Novel, not yet authorisedCA licensed ingredient
also: Aceranthus macrophyllus Blume ex K.Koch, Aceranthus sagittatus Siebold & Zucc., Aceranthus triphyllus K.Koch, Epimedium coactum var. longtouhum H.R.Liang, Epimedium ikariso Siebold ex Regel, Epimedium sagittatum var. glabratum T.S.Ying, Epimedium sagittatum var. oblongifoliolatum Z.Cheng, Epimedium sagittatum var. sagittatum, Epimedium sagittifolius Farrer, Epimedium sinense Siebold ex Miq.
Market presence194 Canadian licensed products
Parts in scopeWhole
Etalyn identifierETA-C-005720
Epimedium wushanense CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005721
Epimedium Wushanense Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005722
Epinastine US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic Agonists [MoA]; Adrenergic Receptor Agonist [EPC]; Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]
Earliest US approval2003
Market presence3 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005723
Epinephrine CA-NHPEU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedCA licensed ingredientUS: anda
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Earliest US approval1948
Market presence411 US product listings · 94 FDA applications · 2 EU medicines · 5 Canadian licensed products
Etalyn identifierETA-C-005724
Epiphegus virginiana CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005726
Epirubicin Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAnthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]
Earliest US approval1999
Market presence5 US product listings · 15 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005727
Epitalon ETALYNUS-DRUG E/insufficientband 6
US: bulk ingredient
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005728
Epizootic hemorrhagic disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005729
Eplerenone US-DRUG Not yet graded
US: anda
Class as recordedAldosterone Antagonist [EPC]; Aldosterone Antagonists [MoA]
Earliest US approval2002
Market presence35 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005730
Eplontersen EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedAntisense Oligonucleotide [EPC]; Antisense [CS]; Decreased RNA Integrity [PE]; Increased Protein Breakdown [PE]
Earliest US approval2023
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005731
Epoetin US-DRUG Not yet graded
US: bla
Class as recordedErythropoiesis-stimulating Agent [EPC]; Erythropoietin [CS]; Increased Erythroid Cell Production [PE]
Market presence34 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005732
Epoetin Alfa-Epbx US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005734
epoetin beta EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB03XA01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005735
epoetin delta EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedB03XA
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005736
epoetin theta EU-MED Not yet graded
EU medicine: Application withdrawn, Authorised
Class as recordedB03XA01
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005737
epoetin zeta EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB03XA01
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005738
Epoprostenol US-DRUG Not yet graded
US: anda
Class as recordedProstacycline Vasodilator [EPC]; Prostaglandins I [CS]; Vasodilation [PE]
Earliest US approval1995
Market presence15 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005739
eprodisate disodium EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005741
Eprosartan Mesylate US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1997
Market presence6 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005742
Epsilon-caroten-3 CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005743
Epsiprantel US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005744
Epstein Barr CA-NHP Not yet graded
CA licensed ingredient
Market presence22 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005745
eptacog alfa (activated) EU-MED Not yet graded
EU medicine: Application withdrawn, Authorised
Class as recordedB02BD08
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005746
Eptacog beta (activated) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB02BD08
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005747
Eptifibatide EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedB01AC16; Decreased Platelet Aggregation [PE]; Platelet Aggregation Inhibitor [EPC]
Earliest US approval1998
Market presence25 US product listings · 15 FDA applications · 2 EU medicines
Etalyn identifierETA-C-005748
Eptinezumab EU-MEDUS-DRUG Not yet graded
Eptinezumab-Jjmr US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005750
eptotermin alfa EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedM05BC02
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005751
Equazen eye q® EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Equazen eye q® (composition of EPA: DHA:GLA at a 9:3:1 ratio) improves reading ability and related cognitive functions in children.” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005752
Equilin US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005753
Equine Botulinum Neurotoxin A Immune FAB2 US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005754
Equine Botulinum Neurotoxin B Immune FAB2 US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005755
Equine Botulinum Neurotoxin C Immune FAB2 US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005756
Equine Botulinum Neurotoxin D Immune FAB2 US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005757
Equine Botulinum Neurotoxin E Immune FAB2 US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005758
Equine Botulinum Neurotoxin F Immune FAB2 US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005759
Equine Botulinum Neurotoxin G Immune FAB2 US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005760
equine herpesvirus 1 EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedQI05AA05
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005761
equine influenza-virus strains: A/equine-2/South Africa/4/03 EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005762
Equine Thymocyte Immune Globulin US-DRUG Not yet graded
US: bla
Class as recordedAntibody-Surface Protein Interactions [MoA]; Immunoglobulin G [EPC]; Immunoglobulins [CS]; Increased T Lymphocyte Destruction [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005763
equine umbilical cord mesenchymal stem cells EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005764
equine umbilical cord-derived mesenchymal stem cells EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005765
Equiseti herba EU-HERB Not yet graded
Herbal monograph: F: Assessment finalised
also: Horsetail herb; Equisetum arvenseL.
Class as recordedherbal: Urinary tract and genital disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-005766
Equisetum Arvense Branch US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005768
Equisetum arvense Rh CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005769
Equisetum Arvense TOP US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Ascorbic Acid [CS]; Bee Venoms [CS]
Market presence53 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005770
Equisetum Arvense Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005771
Equisetum hiemale CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005772
Equisetum Hyemale CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]
Market presence50 US product listings · 52 Canadian licensed products
Etalyn identifierETA-C-005773
Equisetum Hyemale Whole US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Ascorbic Acid [CS]; Bee Venoms [CS]
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005774
Equol US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAndrogen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]; Antimalarial [EPC]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005775
Equol, (-)- US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAndrogen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]; Antimalarial [EPC]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005776
Equus asinus CA-NHP Not yet graded
CA licensed ingredient
Market presence198 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005777
Equus caballus CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005778
Equus Caballus Dander US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Animal Fur [CS]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005779
Equus Caballus Hair US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Animal Fur [CS]; Cell-mediated Immunity [PE]; Cells
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005780
Equus Caballus Skin US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Animal Fur [CS]; Antigens; Bee Venoms [CS]
Market presence14 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005781
Eragrostis tef EU-NOVEL Not yet graded
Not novel in food
also: Cynodon abyssinicus (Jacq.) Raspail
Parts in scopeSeeds
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005782
Eravacycline Dihydrochloride US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2018
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005784
Erbium US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Ascorbic Acid [CS]
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005785
Erbium Sulfate Octahydrate US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005786
Erdafitinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Fibroblast Growth Factor Receptor Inhibitors [MoA]; Kinase Inhibitor [EPC]
Earliest US approval2019
Market presence5 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005787
Erenumab-Aooe US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005789
Ergocalciferol CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: anda
Class as recordedAllergens [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations
Earliest US approval1941
Market presence49 US product listings · 23 FDA applications · 5 Canadian licensed products
Etalyn identifierETA-C-005790
Ergoloid Mesylates US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1953
Market presence4 US product listings · 34 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005791
Ergonovine Maleate US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005792
Ergotamine US-DRUG Not yet graded
US: anda
Class as recordedCentral Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Ergotamine Derivative [EPC]; Ergotamines [CS]
Earliest US approval1948
Market presence10 US product listings · 11 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005793
Ergotinum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005794
Eribulin EU-MEDUS-DRUG Not yet graded
Ericameria Nauseosa Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005796
Erigeron annuus CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005797
Erigeron breviscapus CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005798
Erigeron Canadensis CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence11 US product listings · 11 Canadian licensed products
Etalyn identifierETA-C-005799
Erigeron Canadensis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005800
Erinaceus amurensis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005801
Eriobotrya Japonica Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005803
Eriocaulon buergerianum CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005804
Eriodictyon californicum CA-NHP Not yet graded
CA licensed ingredient
Market presence45 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005805
Eriodictyon Californicum Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005806
Eriodictyon Californicum Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence15 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005807
Eriogonum ovalifolium CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005808
Erlotinib EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedKinase Inhibitor [EPC]; L01EB02; L01XE03; Protein Kinase Inhibitors [MoA]
Earliest US approval2004
Market presence45 US product listings · 14 FDA applications · 2 EU medicines
Etalyn identifierETA-C-005809
Erodium CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005810
Erodium Cicutarium CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence2 US product listings · 3 Canadian licensed products
Etalyn identifierETA-C-005811
Erodium stephanianum CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005812
Ertapenem Sodium EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedCarbapenems [CS]; J01DH03; Penem Antibacterial [EPC]
Earliest US approval2001
Market presence23 US product listings · 7 FDA applications · 3 EU medicines
Etalyn identifierETA-C-005813
Ertugliflozin US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2017
Market presence4 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005814
Ertugliflozin Pidolate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBiguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]
Market presence18 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005816
Erycibe schmidtii CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005818
Eryngium aquaticum CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005819
Eryngium maritimum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005820
Eryngium Yuccifolium Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005821
Erysimum Cheiri US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005822
Erysimum Cheiri Seed US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAntimalarial [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005823
Erysipelothrix rhusiopathiae EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005824
Erythranthe Cardinalis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005825
Erythranthe Guttata Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005826
Erythrina variegata CA-NHP Not yet graded
CA licensed ingredient
Market presence29 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005827
Erythrite CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005828
Erythroglossum laciniatum EU-NOVEL Not yet graded
Not novel in food
also: Ulva laciniata Lightfoot 1777, Porphyra laciniata (Lightfoot) C.Agardh 1824, Porphyra umbilicalis var. laciniata (Lightfoot) Ruprecht 1850, Porphyra umbilicalis f. laciniata (Lightfoot) Thuret 1863, Porphyra umbilicalis subsp. laciniata (Lightfoot) J.Agardh 1883, Polyneura laciniata (Lightfoot) P.S.Dixon 1983
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005829
Erythromycin US-DRUG Not yet graded
US: anda
Class as recordedDecreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
Earliest US approval1964
Market presence98 US product listings · 93 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005830
Erythromycin Estolate US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1967
Market presence1 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005831
Erythromycin Ethylsuccinate US-DRUG Not yet graded
US: anda
Class as recordedDecreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
Earliest US approval1965
Market presence32 US product listings · 25 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005832
Erythromycin Gluceptate US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005833
Erythromycin Lactobionate US-DRUG Not yet graded
US: anda
Class as recordedDecreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
Earliest US approval1964
Market presence5 US product listings · 12 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005834
Erythromycin Oxime US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005835
Erythromycin Thiocyanate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005836
Erythropoietin US-DRUG Not yet graded
US: drug for further processing
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005837
Erythroxylum catuaba CA-NHP Not yet graded
CA licensed ingredient
Market presence23 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005838